As of 2025-04-22, the Fair Value of Urogen Pharma Ltd (URGN) is -13.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.66 USD, the upside of Urogen Pharma Ltd is -242.48%.
With the market price of 9.66 USD and our fair value calculation, Urogen Pharma Ltd (URGN) is not a good investment. Investing in URGN stocks now will result in a potential loss of 242.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -128.48 | -110.82 | -109.78 | -102.24 | -126.87 | -115.64 |
| YoY growth | -22.19% | 13.75% | 0.94% | 6.86% | -24.09% | -4.95% |
| Market Cap (mil) | 445.23 |
| P/E | |
| Forward P/E |
| EPS | -2.75 |
| Avg earnings growth rate | -4.95% |
| TTM earnings | -126.87 |